SWOT Analysis for Samrat Pharmachem Ltd.

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Profit making Companies with High ROCE and Low PE
Undervalued Growth Stocks
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
PEG lower than Industry PEG
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Companies with rising net profit margins - quarterly as well as TTM basis
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing profits every quarter for the past 4 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Declining Revenue every quarter for the past 3 quarters
Annual net profit declining for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter